Skip to main content

Relias Media has upgraded our site!

Please bear with us as we work through some issues in order to provide you with a better experience.

Thank you for your patience.

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Final CTU new 2019 masthead1

March 1, 2015

View Archives Issues

  • Statistics show more use of LARC — How can you maintain momentum?

    The latest national statistics show that long-acting reversible contraceptives (LARCs) now follow the Pill, sterilization, and condoms as the most common methods currently used by women in the United States.1 However, with 51% of pregnancies unintended in the United States,2 advocates are pushing to improve access to such effective birth control.

  • Family Planning Providers Urged to Focus on Campus Sexual Violence Prevention

    One in five women is sexually assaulted while in college. A White House Task Force wants to strengthen federal enforcement efforts.

  • It’s time for a tiered approach to counseling on emergency contraception

    A recently published commentary calls for changes in patient counseling for emergency contraception (EC).1 Why? Typical counseling does not take into account the relative effectiveness of available methods or patient characteristics, it asserts.

  • Boost HPV vaccine uptake in university settings

    While public health officials advocate for vaccination against human papillomavirus (HPV) in girls and boys ages 11-12, they also call for vaccination of young women ages 13-26 and males ages 13-21 who have not been previously vaccinated or did not complete the three-dose series.

  • Research eyes noninvasive test for endometriosis

    Endometriosis is a common health problem for women. An estimated 11% of U.S. women have the gynecologic disorder, which happens when the lining of the uterus grows outside of the uterus.1 In women with endometriosis, when the endometrial tissue enters the abdominal cavity, it attaches to organs in the abdominal and pelvic cavities, such as the ovaries, the intestines, or other organs or tissues. This tissue continues to follow the monthly menstrual cycle, and the resulting bleeding can cause inflammation, scarring, and pain. It is prevalent in 38% of infertile women and in 71-87% of women with chronic pelvic pain.2

  • Medicaid is making an impressive impact

    The year 2015 is shaping up to be another big one for the joint federal-state Medicaid program. It is the second year of the Affordable Care Act’s (ACA’s) broad expansion of Medicaid to individuals below 138% of the federal poverty level. Medicaid enrollment surged in 2014, which helped to drive down uninsurance nationwide. By October 2014, 68.5 million individuals were enrolled in Medicaid, an increase of 9.7 million, or 17%, from the average monthly enrollment in July to that of September 2013.1 That enrollment is in addition to the 950,000-person increase in enrollment among six states and the District of Columbia that had chosen to expand Medicaid prior to 2014.

  • Some groups continue to bear disproportionate burden of STIs

    While the latest national surveillance data show signs of progress in reducing chlamydia and gonorrhea among young people ages 15-24, the numbers and rates of reported cases of these two diseases continue to be highest in this group compared to other age groups.1

  • New HPV vaccine covers 9 types of HPV

    Get ready to include a new human papillomavirus (HPV) vaccine at your facility. The Food and Drug Administration (FDA) has approved Gardasil 9 from Kenilworth, NJ-based Merck Sharp & Dohme Corp., a subsidiary of Merck & Co.